JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 13 No. 7 498-503
© 1972 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheffel, U.
Right arrow Articles by Wagner, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheffel, U.
Right arrow Articles by Wagner, H. N., Jr.

Albumin Microspheres for Study of the Reticuloendothelial System

Ursula Scheffel, Buck A. Rhodes, T. K. Natarajan and Henry N. Wagner, Jr.

The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: Ursula Scheffel, Dept. of Radiological Science, The Johns Hopkins Medical Institutions, 615 North Wolfe St., Baltimore, Md. 21205.

ABSTRACT

An improved method for the preparation of HSA microspheres with an average diameter of 0.5–0.7 microns and narrow particle-size range, suitable for the study of the RES, has been described. No toxic effects towards the new drug were observed in animals. Nonradioactive HSA spheres could be stored for more than 10 months. Labeling of the spheres with 99mTc was carried out under sterile conditions immediately before use. The tagging efficiency was 65–83%, and the labeled product was stable for up to 20 hr. When injected intravenously, about 90% of the 99mTc microspheres were extracted by the liver. Blood clearance studies in dogs showed small variability in day-to-day preparations. The advantage of this new drug over the widely used 99mTc-sulfur-colloid is that it can be used for the assessment of RES functions in addition to scanning the distribution of the RES.




This article has been cited by other articles:


Home page
Journal of Bioactive and Compatible PolymersHome page
E. Chiellini, E. E. Chiellini, F. Chiellini, and R. Solaro
Targeted Administration of Proteic Drugs. I. Preparation of Polymeric Nanoparticles
Journal of Bioactive and Compatible Polymers, November 1, 2001; 16(6): 441 - 465.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1972 by the Society of Nuclear Medicine.